Paulson & Co. - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$20,405,000
-46.5%
350,000
-30.0%
1.01%
-14.4%
Q1 2022$38,160,000
-62.8%
500,000
-70.7%
1.18%
-62.9%
Q4 2021$102,626,000
+45.5%
1,705,599
+35.4%
3.16%
+57.5%
Q3 2021$70,533,000
-8.7%
1,259,518
-1.1%
2.01%
+8.8%
Q2 2021$77,255,000
-22.0%
1,273,161
-10.0%
1.85%
-18.9%
Q1 2021$99,097,000
+17.1%
1,413,8540.0%2.28%
+3.6%
Q4 2020$84,605,000
+12.1%
1,413,854
+12.6%
2.20%
-6.7%
Q3 2020$75,487,000
+11.5%
1,255,608
-2.7%
2.35%
+8.8%
Q2 2020$67,683,000
+17.6%
1,289,941
-24.9%
2.16%
-1.5%
Q1 2020$57,562,000
-26.0%
1,716,7270.0%2.20%
+30.8%
Q4 2019$77,768,000
+19.0%
1,716,7270.0%1.68%
+28.3%
Q3 2019$65,356,000
+56.7%
1,716,727
+79.0%
1.31%
+84.6%
Q2 2019$41,707,000
+119.2%
958,997
+91.8%
0.71%
+249.3%
Q1 2019$19,030,000500,0000.20%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
GAGNON SECURITIES LLC 563,415$21,753,4534.80%
Gagnon Advisors, LLC 180,331$6,962,5794.70%
Spyglass Capital Management LLC 868,686$33,539,9662.69%
Tamarack Advisers, LP 100,000$3,861,0001.99%
ARMISTICE CAPITAL, LLC 1,892,000$73,050,1201.27%
NEUMEIER POMA INVESTMENT COUNSEL LLC 276,590$10,679,1400.99%
RICE HALL JAMES & ASSOCIATES, LLC 437,285$16,883,5740.97%
Rock Springs Capital Management LP 1,032,600$39,868,6860.96%
OUTFITTER FINANCIAL LLC 25,860$998,4550.91%
Stephens Investment Management Group LLC 1,168,469$45,535,2370.82%
View complete list of PACIRA PHARMACEUTICALS INC shareholders